CPXCX
Price
$12.12
Change
+$0.02 (+0.17%)
Updated
Jun 3 closing price
Net Assets
7.6B
PNARX
Price
$9.13
Change
+$0.01 (+0.11%)
Updated
Jun 3 closing price
Net Assets
5.51B
Interact to see
Advertisement

CPXCX vs PNARX

Header iconCPXCX vs PNARX Comparison
Open Charts CPXCX vs PNARXBanner chart's image
Cohen & Steers Preferred Sec & Inc C
Price$12.12
Change+$0.02 (+0.17%)
VolumeN/A
Net Assets7.6B
Principal Spectrum Pref&Cptl Scs IncR3
Price$9.13
Change+$0.01 (+0.11%)
VolumeN/A
Net Assets5.51B
CPXCX vs PNARX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CPXCX vs. PNARX commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPXCX is a StrongBuy and PNARX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CPXCX has more cash in the bank: 7.6B vs. PNARX (5.51B). PNARX pays higher dividends than CPXCX: PNARX (4.95) vs CPXCX (4.65). CPXCX was incepted earlier than PNARX: CPXCX (15 years) vs PNARX (21 years). CPXCX (1.79) is less costly to investors than PNARX (1.27). CPXCX is a more actively managed with annual turnover of: 66.00 vs. PNARX (22.30). CPXCX (0) and PNARX (0) have matching initial minimum investment requirements. PNARX annual gain was more profitable for investors over the last year : 6.70 vs. CPXCX (6.21). CPXCX (13.32) and PNARX (13.25) have equivalent 5 years return.
CPXCXPNARXCPXCX / PNARX
Total Expense Ratio1.791.27141%
Annual Report Gross Expense Ratio1.791.27141%
Fund Existence15 years21 years-
Gain YTD1.2772.01363%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets7.6B5.51B138%
Annual Yield % from dividends4.654.9594%
Returns for 1 year6.216.7093%
Returns for 3 years11.7512.2596%
Returns for 5 years13.3213.25101%
Returns for 10 years39.8835.85111%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSQAX23.820.17
+0.72%
Russell Inv Equity Income A
FIVUX33.82N/A
N/A
Macquarie Opportunity Instl
MRJSX10.74N/A
N/A
Morgan Stanley Multi-Asset Real ReturnR6
CSXAX49.46N/A
N/A
Calvert US Large Cap Core Rspnb Idx A
LGOAX36.07N/A
N/A
Patient Opportunity A